Department of Child and Adolescent Psychiatry, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital of Zurich, Zurich, Switzerland.
Obes Facts. 2023;16(1):99-107. doi: 10.1159/000527386. Epub 2022 Nov 8.
Off-label treatment of a 15-year-old female patient with anorexia nervosa (AN) with human recombinant leptin (metreleptin) for nine days was associated with self-reported increments of appetite and hunger resulting in rapid weight gain and substantial improvement of eating disorder cognitions and of depression. The results further substantiate the effects of metreleptin on both AN and depression. We contrast these results with the widespread view that leptin is an anorexigenic hormone. Randomized controlled trials are warranted to confirm the described effects.
对一名患有神经性厌食症(AN)的 15 岁女性患者进行为期九天的人重组瘦素(metreleptin)的标签外治疗,患者自述食欲和饥饿感增加,导致体重迅速增加,饮食障碍认知和抑郁症状显著改善。这些结果进一步证实了 metreleptin 对 AN 和抑郁症的影响。我们将这些结果与瘦素是一种厌食激素的普遍观点形成对比。需要进行随机对照试验来证实所描述的效果。